Casdin Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
2021
Q4
$20.2M Hold
2021
Q3
$29.8M Hold
2021
Q2
$43.1M Hold
2021
Q1
$32.5M Hold
2020
Q4
$40.8M Hold
2020
Q3
$22.3M Hold
2020
Q2
$19.6M Hold
2020
Q1
$11.3M Buy
2018
Q4
Sell
2018
Q3
$9.76M Hold
2018
Q2
$12.9M Buy
2018
Q1
$6.17M Buy